iShares Morningstar Large-Cap Growth ETFの空売り状況は、投資家がiShares Morningstar Large-Cap Growth ETFの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

iShares Morningstar Large-Cap Growth ETF (ARCA:ILCG), 空売り情報

Technology

Consumer Cyclical

Communication Services

Financial Services

Industrials

Healthcare

Consumer Defensive

Real Estate

Basic Materials

Utilities

Energy

The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of stocks issued by large-capitalization companies that have exhibited above-average growth characteristics as determined by Morningstar, Inc.s (Morningstar or the index provider) proprietary index methodology.

Microsoft Corp

Nvidia Corp.

Amazon.Com Inc

Apple Inc

Eli Lilly & Co.

Tesla, Inc.

Meta Platforms, Inc.

Alphabet Inc.Class A

Alphabet Inc. C

Visa Inc

Broadcom Inc

iShares Morningstar Growth ETF

iShares Morningstar Large-Cap Growth ETF

WIIM

CSCO

AlibabaCisco Systems shares are trading higher after the company reported better-than-expected Q3 financial results, raised its FY25 guidance, and issued Q4 adjusted EPS guidance above estimates.

Major cryptocurrencies are trading lower in early Thursday hours despite ongoing institutional demand and <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45374267/inflation-eases-in-april-as-trumps-tariffs-dont-push-prices-higher">cooling inflation data.</a>
Sentiment has shifted sharply, with the Crypto Fear &amp; Greed Index entering the &#8216;Greed&#8217; zone, raising questions whether this pullback signals a phase of profit-taking and consolidation following the robust rally over the past few weeks.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$101,782.26</td>
<td>-1.9%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,537.22</td>
<td>-2.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$169.23</td>
<td>-5.7%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.45</td>
<td>-5.6%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2232</td>
<td>-5.2%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001484</td>
<td>-7.1%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows Bitcoin and Ethereum large transaction volume dropped 5.1% and 0.2%, respectively, in a single day. While ETH shows a 240% rise in exchange netflows, Bitcoin's daily active addresses are down 1.9%.</li>
<li>Coinglass data shows 157,967 traders were liquidated in the past 24 hours for $346.93 million.</li>
<li>SoSoValue data shows that spot Bitcoin ETFs saw a net inflow of $319.6 million, while spot Ethereum ETFs saw a $63.5 million net inflow.</li>
<li>Santiment data <a href="https://x.com/santimentfeed/status/1922717938986922260">shows</a> the daily average of new wallet creations over the past month: Bitcoin leads with 309,000 new wallets per day, followed by Ethereum at 112,000, USDT at 36,400, and XRP with 3,500 daily.</li>
<li>According to CoinMarketCap, the Crypto Fear &amp; Greed Index has surged to 71, entering the Greed zone, up sharply from the neutral range (40–60) recorded in early May.</li>
</ul>
Trader Notes: Bitcoin is finding key support around $101,600, according to crypto chart analyst Ali Martinez.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Key support for <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> right now is at $101,600! <a href="https://t.co/4cOpEJAPuA">pic.twitter.com/4cOpEJAPuA</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1922913059825189315?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, trader Adam <a href="https://x.com/abetrade/status/1922950159354175810">observed</a> that Bitcoin appears exhausted after its climb to $105,000, with open interest returning to levels seen near previous all-time highs. 
He notes that spot markets are encountering increased selling pressure, and while the move from $80,000 suggests a solid base, this may not be an optimal time to open new long positions.
Martinez also <a href="https://x.com/ali_charts/status/1922941887326917041">highlighted</a> that Ethereum has closed above its 200-period simple moving average on the 3-day chart, currently around $2,700. 
Historically, such a close has marked the beginning of major bull rallies for ETH.
For Solana, analyst Crypto Zeinab <a href="https://x.com/CryptoZeinab/status/1922949454367265013">notes</a> that the coin is currently retesting the $180 breakout level. 
A successful bullish retest could open the path toward $200. 
Supporting this outlook, Glassnode<a href="https://x.com/glassnode/status/1922931170691412455"> data</a> shows positive 30-day capital inflows of around 4–5% for SOL after months of outflows, signalling renewed investor interest, now on par with XRP.
Bluntz Capital pointed out that Dogecoin is forming a textbook inverse head and shoulders (IHS) pattern. The breakout occurred with strong volume, and the current pullback is seen as a healthy consolidation, potentially setting up for further upside.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">quite liking <a href="https://twitter.com/search?q=%24doge&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$doge</a> here aswell for continued upside, textbook IHS with volume in the breakout with a nice pullback here <a href="https://t.co/7iYf5fk9Vo">pic.twitter.com/7iYf5fk9Vo</a>
&mdash; Bluntz (@Bluntz_Capital) <a href="https://twitter.com/Bluntz_Capital/status/1922845477512372626?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet">Michael Saylor&#8217;s Bitcoin Strategy—&#8217;Infinite Money Glitch&#8217; Or A Reflexive Leverage Bet?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Down As Sentiment Turns To Greed

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) with a Buy and maintains $16 price target.

Price Target

Reiteration

Analyst Ratings

CALC

HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

UnitedHealth shares are trading lower amid reports indicating the company is under investigation by the US Department of Justice for possible Medicare fraud.

Guidance

Legal

COIN

Coinbase Has Preliminarily Estimated Expenses To Be Within The Range Of ~$180M To $400M Relating To Remediation Costs, Voluntary Customer Reimbursements Relating To Cyber Incident

Rhino Resources, Halliburton Complete First Namibia Offshore Wells Using Local Infrastructure

Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) reported quarterly earnings of $2.09 per share which beat the analyst consensus estimate of $(8.04) by 126 percent. This is a 135.3 percent increase over losses of $(5.92) per share from the same period last year. The company reported quarterly sales of $57.00 thousand which missed the analyst consensus estimate of $60.00 thousand by 5.00 percent. This is a 1.79 percent increase over sales of $56.00 thousand the same period last year.

Earnings

Earnings Beats

Earnings Misses

TRAW

Traws Pharma Q1 EPS $2.09 Beats $(8.04) Estimate, Sales $57.00K Miss $60.00K Estimate

Walmart shares are trading higher following Q1 financial results.

SBC Medical Group Unveils $5M Share Buyback Plan, Citing Undervalued Stock And Growth Potential

HC Wainwright &amp; Co. analyst Mitchell Kapoor upgrades CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) from Neutral to Buy and maintains the price target from $5 to $5.

Upgrades

CTMX

HC Wainwright & Co. Upgrades CytomX Therapeutics to Buy, Maintains Price Target to $5

<figure class="table"> 
<table>
<tbody>
<tr>
<td>-</td>
<td>CLIK will collaborate with Flash Mutual, an advanced technology company under the Tencent SSV initiatives, to jointly promote 24-hour instant device services for senior citizens in Hong Kong</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>-</td>
<td>Tencent SSV is an initiative launched by Tencent, a world leading internet and technology company, aiming to leverage its unique digital platform and technology to drive Sustainable Social Value (SSV) globally</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>-</td>
<td>CLIK also announces the appointment of Mr. Lam Kai Yuen, Gabi as the new independent director</td>
</tr>
</tbody>
</table>
</figure>

Contracts

General

CLIK

Click Holdings Signed A Cooperation Agreement With Flash Mutual Technology In Which Both Parties Agreed To Jointly Promote 24-Hour Instant Device Service For Senior Citizens In Hong Kong

PYXS

Pyxis Oncology Q1 EPS $(0.35) Misses $(0.29) Estimate

Fonar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FONR#NASDAQ">FONR</a>) reported quarterly earnings of $0.37 per share. This is a 37.04 percent increase over earnings of $0.27 per share from the same period last year. The company reported $27.16 million in sales this quarter. This is a 5.63 percent increase over sales of $25.72 million the same period last year.

FONR

Fonar Q3 EPS $0.37 Up From $0.27 YoY, Sales $27.16M Up From $25.72M YoY

Enbridge Sells 12.5% Stake In Westcoast Gas Pipeline To Indigenous Alliance In C$715M Deal

Needham analyst Scott Berg reiterates Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) with a Buy and maintains $40 price target.

GLBE

Needham Reiterates Buy on Global E Online, Maintains $40 Price Target

Following the issuance of the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnmg.com%2Fupdated-feasibility-study%2F&amp;esheet=54255452&amp;newsitemid=20250515626279&amp;lan=en-US&amp;anchor=NI+43-101+Updated+Technical+Feasibility+Study+Report+for+the+Matawinie+Mine+and+B%26eacute%3Bcancour+Battery+Material+Plant+Integrated+Graphite+Projects&amp;index=1&amp;md5=b166f23d4579e193f536dd82cfc58585">NI 43-101 Updated Technical Feasibility Study Report for the Matawinie Mine and Bécancour Battery Material Plant Integrated Graphite Projects</a> (the "Updated Feasibility Study"), Nouveau Monde Graphite Inc. ("NMG" or the "Company") ((<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;,%20url=https%3A%2F%2Fwww.nyse.com%2Fquote%2FXNYS%3ANMG&amp;,%20esheet=54255452&amp;,%20newsitemid=20250515626279&amp;,%20lan=en-US&amp;,%20anchor=NYSE%3A+NMG&amp;,%20index=2&amp;,%20NYSE:%3Ca%20class=">NMG</a>, <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;,%20url=https%3A%2F%2Fmoney.tmx.com%2Fen%2Fquote%2FNOU&amp;,%20esheet=54255452&amp;,%20newsitemid=20250515626279&amp;,%20lan=en-US&amp;,%20anchor=TSX%3A+NOU&amp;,%20index=3&amp;,%20TSX:%3Ca%20class=">NOU</a>) is advancing its Phase-2 commercial plans with progressing work on the project financing, engineering, procurement and construction preparation. The Company also files its <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnmg.com%2Fwp-content%2Fuploads%2F2025%2F05%2FNMG-2024-ESG-Report.pdf&amp;esheet=54255452&amp;newsitemid=20250515626279&amp;lan=en-US&amp;anchor=2024+ESG+Report&amp;index=4&amp;md5=1a85134dab09a1d58a4959d289f6824c">2024 ESG Report</a> that demonstrates continued stewardship of environmental, social and governance ("ESG") issues aligned with global decarbonization efforts and international standards as required by lenders, investors, and customers.
&nbsp;
Arne H Frandsen, Chair of NMG, said: "NMG is cleverly navigating the shifting global market, while steadfastly maintaining its ESG commitments. Our business model, rooted in the clean energy transition, strives to capitalize on Western economies' growing appetite for critical minerals, local and ESG-compliant supply chains, as well as reshoring manufacturing capacity. Our commercial agreements with Panasonic Energy and General Motors along with strong interest from strategic lenders and institutional investors strengthen our plans to develop a responsible and carbon-neutral source of active anode material, positioning NMG as a sustainable and innovative supplier for long-term growth."
Eric Desaulniers, Founder, President, and CEO of NMG, declared: "Consumer demand for electric vehicles ("EV") is undisputable and catalyzes the battery value chain, a strong driver for active anode material. Facing steep tariffs and tightening supplies, manufacturers are seeking alternatives to Chinese active anode material. NMG's ore-to-battery-material Phase-2 Matawinie Mine and Bécancour Battery Material Plant are timely set to enter market, offering simplified trade corridors, ESG compliance, reliability, and a scalable source."

NMG Advances Phase-2 Graphite Plans Amid Rising EV Demand and Feasibility Study Update

Edap TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDAP#NASDAQ">EDAP</a>) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.15) by 33.33 percent. This is a 53.85 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $14.28 million which missed the analyst consensus estimate of $14.90 million by 4.14 percent. This is a 11.45 percent decrease over sales of $16.13 million the same period last year.

EDAP

Edap TMS Q1 EPS $(0.20) Misses $(0.15) Estimate, Sales $14.28M Miss $14.90M Estimate

LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.74) by 41.89 percent. This is a 272.13 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $2.37 million which missed the analyst consensus estimate of $2.85 million by 16.81 percent. This is a 50.06 percent decrease over sales of $4.75 million the same period last year.

LMFA

LM Funding America Q1 EPS $(1.05) Misses $(0.74) Estimate, Sales $2.37M Miss $2.85M Estimate

Voyager Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase (ALPL) to transport a novel AAV capsid across the blood-brain barrier (BBB). The article, titled "Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier," was published in Molecular Therapy and can be accessed <a href="https://www.globenewswire.com/Tracker?data=cj67Y-Knq303UIC-gtuXKW-aBxpe4WTcmnyda8PFmxVBLy2QEO7snPUifGEewxYoRNRUyW4tCr6zG09PKuYFg3wXavwAV_q1Erv4Kp6A4hhD-H_PtuyMkQkpb3Y2ZO-3cYvUz_bD-DghzrJopXu_-XMwqHwS3Jg2Z4V3Rk1WujE=">here</a>.

VYGR

Voyager Therapeutics Announces First Peer-Reviewed Publication Of Data Showing Ability Of Alkaline Phosphatase To Transport Novel AAV Capsid Across The Blood-brain Barrier

NVEE

Upon Closing Of The Transaction, Current Acuren Stockholders Will Own ~60%, And Current NV5 Stockholders Will Own ~40% Of The Combined Company

Comments

iShares Morningstar Large-Cap Growth ETF

空売り

iShares Morningstar Large-Cap Growth ETF (ARCA:ILCG), 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル